BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33959473)

  • 1. Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts.
    Hong D; Yang J; Guo J; Zhang Y; Chen Z
    Anal Cell Pathol (Amst); 2021; 2021():8837950. PubMed ID: 33959473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.
    Li J; Zhu P; Wang L; Yang L; Zou L; Gao F
    Cancer Med; 2019 Apr; 8(4):1594-1603. PubMed ID: 30900382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of rosiglitazone and all-trans-retinoic acid on angiogenesis and growth of myeloma xenograft in nude mice].
    Huang HW; Chen P; Li BZ; Fu JX; Li J; Zhang XH; Liu R; Fan YY; Zhang H; Chow HC; Leung AY; Liang R
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):652-7. PubMed ID: 23159076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Targeted Microbubble Destruction Enhances the Antitumor Efficacy of Doxorubicin in a Mouse Hepatocellular Carcinoma Model.
    Wu Y; Sun T; Tang J; Liu Y; Li F
    Ultrasound Med Biol; 2020 Mar; 46(3):679-689. PubMed ID: 31882167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
    Zhu F; Jiang Y; Luo F; Li P
    J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts.
    Pu C; Chang S; Sun J; Zhu S; Liu H; Zhu Y; Wang Z; Xu RX
    Mol Pharm; 2014 Jan; 11(1):49-58. PubMed ID: 24237050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model.
    Shimamoto N; Ito M; Chiba M; Honma S; Imazu H; Sumiyama K
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):478-485. PubMed ID: 32265136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
    Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma.
    Peng C; Wu Y; Yang Y; Li N; Chen X; Gu L; Xu D; Yang C
    J Cancer Res Clin Oncol; 2021 May; 147(5):1355-1363. PubMed ID: 33547949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 16. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer.
    Liu Z; Cheng S; Fu G; Ji F; Wang C; Cao M
    Life Sci; 2020 Jun; 251():117604. PubMed ID: 32243929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer.
    Xiao YF; Liu SX; Wu DD; Chen X; Ren LF
    World J Gastroenterol; 2006 Sep; 12(36):5780-6. PubMed ID: 17007042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus.
    Matsuki M; Adachi Y; Ozawa Y; Kimura T; Hoshi T; Okamoto K; Tohyama O; Mitsuhashi K; Yamaguchi A; Matsui J; Funahashi Y
    Cancer Sci; 2017 Apr; 108(4):763-771. PubMed ID: 28107584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.